Unlock instant, AI-driven research and patent intelligence for your innovation.

Succinic acid amide derivatives of nitro-substituted naphthalene ring, its preparation method and use

An alkyl and compound technology, applied in the preparation of carboxylic acid amides, carboxylic acid nitriles, and organic compounds, etc., can solve the problems of allopurinol liver and bone marrow toxicity, allergy, fulminant hepatitis, etc.

Active Publication Date: 2016-05-18
茅婷婷
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These drugs have different degrees of toxic and side effects, such as benzbromarone has the risk of causing fulminant hepatitis, allopurinol has adverse reactions such as liver and bone marrow toxicity and allergic reactions, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Succinic acid amide derivatives of nitro-substituted naphthalene ring, its preparation method and use
  • Succinic acid amide derivatives of nitro-substituted naphthalene ring, its preparation method and use
  • Succinic acid amide derivatives of nitro-substituted naphthalene ring, its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] .

[0030] A. Synthesis of Compound IV-1

[0031] 3.76g (20mmol) of compound II-1 and 2.64g (20mmol) of compound III were dissolved in 50mL of dry THF, stirred under cooling in an ice-water bath, and 4.13g (20mmol) of dicyclohexylcarbodiimide (DCC) and 4- Dimethylaminopyridine (DMAP) 0.61 g (5 mmol), then stirred at room temperature until the reaction was detected by TLC (within 12 h). The reaction mixture was poured into 300 mL of ice water, stirred, using 100 mL × 3 CH 2 Cl 2 Extract, combine the extract phases, successively wash with 100mL of 1% dilute hydrochloric acid and 100mL of 5% brine, and dry over anhydrous sodium sulfate. The desiccant was removed by suction filtration, the filtrate was evaporated to dryness on a rotary evaporator, and the obtained residue was purified by column chromatography to obtain compound IV-1, a white solid, ESI-MS, m / z=325 ([M+Na] + ).

[0032] B. Synthesis of Compound V-1

[0033] Compound IV-14.53g (15mmol) was dissolved i...

Embodiment 2-13

[0038] With reference to the operating steps of Example 1, the compounds listed in the following table were prepared:

[0039]

Embodiment 9

[0041] The compounds of the present invention and related compounds inhibit IC of URAT1 50 The values ​​are determined in a similar manner as described in the literature (Example 12 in US2014 / 0005136). The results are listed below.

[0042] Construction of a cell line stably expressing the humanized URAT1 transporter: The humanized URAT1 gene (SLC22A112) was subcloned from the plasmid pCMV6-XL-5 (Origene) into the eukaryotic expression plasmid pCMV6 / neo (Origene). Gene sequencing confirmed that the humanized URAT1 was consistent with the information recorded in the gene bank (NM_144585.2). HEK293 human embryonic kidney cells (ATCC#CRL-1573) were cultured in EMEM tissue culture medium under 5% CO 2 and 95% air atmosphere. pCMV6 / Neo / URAT1 was transfected onto HEK293 cells using L2000 type transfection reagent (Invitrogene). After 24 hours, the transfected cells were divided into tissue culture dishes with a diameter of 10 cm, continued to grow for one day, and then the mediu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicines related to hyperuricemia and gout, and particularly relates to urate transporter 1 inhibitors having structures of nitronaphthalene-ring-containing butanedioic acid amides, a preparing method thereof, pharmaceutical compositions containing the inhibitors and applications of the inhibitors in preparation of medicines for diabetes. A formula (I) is shown in the specification, wherein R1 is selected from -NO2 and -CN, and R2 is selected from H, C1-C5 alkyl and C3-C6 cycloalkyl.

Description

technical field [0001] The invention relates to the field of drugs related to the treatment of hyperuricemia and gout. Specifically, the present invention relates to a class of uric acid transporter 1 (uratetransporter1, URAT1) inhibitors containing nitro-substituted naphthalene ring-containing succinic acid amide derivatives that have a therapeutic effect on hyperuricemia and gout, a preparation method, and contain Their pharmaceutical compositions and their use in medicine. Background technique [0002] Gout is a chronic metabolic disease characterized by hyperuricemia and pain caused by deposition of monosodium uric acid (MSU) in joints and other parts. The main reason is purine metabolism disorder and / or uric acid excretion disorder. It is estimated that there are more than 20 million gout patients worldwide. Drugs currently used to treat gout include anti-inflammatory drugs for pain relief (such as colchicine, etc.), drugs that inhibit uric acid production (xanthine o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C231/02C07C233/15C07C253/30C07C255/60A61K31/167A61K31/277A61P19/06
Inventor 不公告发明人
Owner 茅婷婷